|
PLEKHA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.664380E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.470000E-02 |
| Normal-vs-Stage2 |
8.223900E-02 |
| Normal-vs-Stage3 |
2.120200E-01 |
| Normal-vs-Stage4 |
1.191010E-01 |
| Stage1-vs-Stage2 |
3.885400E-01 |
| Stage1-vs-Stage3 |
9.539800E-01 |
| Stage1-vs-Stage4 |
8.243600E-01 |
| Stage2-vs-Stage3 |
4.816000E-01 |
| Stage2-vs-Stage4 |
7.169000E-01 |
| Stage3-vs-Stage4 |
8.101400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.702900E-03 |
| Normal-vs-AfricanAmerican |
1.787150E-01 |
| Normal-vs-Asian |
3.200000E-01 |
| Caucasian-vs-AfricanAmerican |
3.064400E-01 |
| Caucasian-vs-Asian |
4.594000E-04 |
| AfricanAmerican-vs-Asian |
3.659800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.071600E-02 |
| Normal-vs-Female |
5.399500E-02 |
| Male-vs-Female |
9.158200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.838800E-01 |
| Normal-vs-Extreme_Weight |
2.014000E-01 |
| Normal-vs-Obese |
2.394100E-02 |
| Normal-vs-Extreme_Obese |
2.970400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.811200E-01 |
| Normal_Weight-vs-Obese |
3.148400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.285600E-01 |
| Extreme_Weight-vs-Obese |
2.093800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.003400E-01 |
| Obese-vs-Extreme_Obese |
7.076200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.481400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.479580E-03 |
| Normal-vs-Age(61-80Yrs) |
1.376440E-01 |
| Normal-vs-Age(81-100Yrs) |
9.146000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.886200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.549400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.284300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.038620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.227800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.322800E-03 |
| Normal-VS-Type2 PRCC |
6.171800E-02 |
| Normal-VS-KIRP CIMP |
7.428800E-01 |
| Normal-VS-Unclassified PRCC |
2.491600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.253800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.300400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.230400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.781600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.098600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.351200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.057800E-01 |
| Normal-vs-N1 |
1.108990E-01 |
| Normal-vs-N2 |
3.356600E-01 |
| N0-vs-N1 |
5.561800E-01 |
| N0-vs-N2 |
8.474200E-01 |
| N1-vs-N2 |
9.272000E-01 |
|
|
